chr17-49133190-T-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The ENST00000300404.2(B4GALNT2):ā€‹c.165T>Gā€‹(p.Phe55Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000179 in 1,507,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00011 ( 0 hom., cov: 31)
Exomes š‘“: 0.0000074 ( 0 hom. )

Consequence

B4GALNT2
ENST00000300404.2 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.109
Variant links:
Genes affected
B4GALNT2 (HGNC:24136): (beta-1,4-N-acetyl-galactosaminyltransferase 2 (SID blood group)) B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06610456).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
B4GALNT2NM_001159387.2 linkuse as main transcriptc.14+384T>G intron_variant ENST00000393354.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
B4GALNT2ENST00000300404.2 linkuse as main transcriptc.165T>G p.Phe55Leu missense_variant 1/111 Q8NHY0-1
B4GALNT2ENST00000393354.7 linkuse as main transcriptc.14+384T>G intron_variant 1 NM_001159387.2 P1Q8NHY0-2
B4GALNT2ENST00000504681.5 linkuse as main transcriptc.-65+680T>G intron_variant 2 Q8NHY0-3

Frequencies

GnomAD3 genomes
AF:
0.000118
AC:
18
AN:
151954
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000435
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000906
AC:
1
AN:
110378
Hom.:
0
AF XY:
0.0000162
AC XY:
1
AN XY:
61780
show subpopulations
Gnomad AFR exome
AF:
0.000291
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000738
AC:
10
AN:
1355674
Hom.:
0
Cov.:
34
AF XY:
0.00000896
AC XY:
6
AN XY:
669812
show subpopulations
Gnomad4 AFR exome
AF:
0.000328
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000179
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
152072
Hom.:
0
Cov.:
31
AF XY:
0.0000807
AC XY:
6
AN XY:
74344
show subpopulations
Gnomad4 AFR
AF:
0.000410
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000431
Hom.:
0
Bravo
AF:
0.000185
ESP6500AA
AF:
0.000487
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000179
AC:
2
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 07, 2024The c.165T>G (p.F55L) alteration is located in exon 1 (coding exon 1) of the B4GALNT2 gene. This alteration results from a T to G substitution at nucleotide position 165, causing the phenylalanine (F) at amino acid position 55 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
7.5
DANN
Benign
0.79
DEOGEN2
Benign
0.044
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.031
N
LIST_S2
Benign
0.32
T
M_CAP
Benign
0.0016
T
MetaRNN
Benign
0.066
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-0.19
N
REVEL
Benign
0.085
Sift
Benign
0.15
T
Sift4G
Benign
0.78
T
Polyphen
0.72
P
Vest4
0.21
MutPred
0.30
Gain of helix (P = 0.0854);
MVP
0.35
MPC
0.24
ClinPred
0.062
T
GERP RS
-0.26
Varity_R
0.085
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs376859051; hg19: chr17-47210552; API